Circulogene Theranostics Partners With UAB to Research Liquid Biopsy Effectiveness
by Traci Bratton
Alabama-based molecular diagnostics company Circulogene Theranostics announced today that it has signed a research agreement with the University of Alabama Birmingham (UAB) Comprehensive Cancer Center to investigate the efficacy of liquid biopsy for tumor detection and monitoring.